JAK family inhibitors for autoimmune diseases
RM Borzilleri, AC Hart, R Moslin… - … Chemistry and Drug …, 2003 - Wiley Online Library
The JAK family of non‐receptor tyrosine kinases mediates the signaling of proinflammatory
cytokines that contribute to the pathogenesis of numerous autoimmune diseases. While …
cytokines that contribute to the pathogenesis of numerous autoimmune diseases. While …
[PDF][PDF] Thromboembolic adverse drug reactions in janus kinase (Jak) inhibitors
PJ Kotyla, M Engelmann, J Giemza-Stokłosa, B Wnuk… - 2021 - research.birmingham.ac.uk
Recent advances in immunology enabled the characterization of several signal transmitting
pathways responsible for proper cytokine and chemokine signaling. Among them, Janus …
pathways responsible for proper cytokine and chemokine signaling. Among them, Janus …
Intestinalna tkivna ekspresija IL17A, IL17F, IL23A i TLR9 gena u zapaljenskim bolestima creva
S Dragašević - Универзитет у Београду, 2020 - nardus.mpn.gov.rs
Zapaljenske bolesti creva (ZBC) su hronične, idiopatske bolesti u koje spadaju Kronova
bolest (KB) i ulcerozni kolitis (UK). Nastanak ZBC je posledica poremećenog imunološkog …
bolest (KB) i ulcerozni kolitis (UK). Nastanak ZBC je posledica poremećenog imunološkog …
Inhibitors of tyrosine kinase 2 mediated signaling
MA Argiriadi, EC Breinlinger, EYT Chien… - US Patent …, 2019 - Google Patents
2019-07-23 Assigned to ABBVIE INC. reassignment ABBVIE INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VAN EPPS, STACY …
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VAN EPPS, STACY …
[PDF][PDF] Recherche de mutations pathogéniques par analyses d'exomes de larges échantillons de patients: application à la tuberculose
G Kerner - 2020 - theses.md.univ-paris-diderot.fr
Le cadre général de mon projet se situe dans la recherche de gènes contribuant à la
prédisposition ou à la résistance à la tuberculose en se servant des exomes non seulement …
prédisposition ou à la résistance à la tuberculose en se servant des exomes non seulement …
[引用][C] TARGETING SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
S Leit, B Srivastava, NE Genung… - 2023 Medicinal …, 2023 - ACS Publications